Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34+/CD38- early progenitors cultured over human MSCs as a feeder layer

Stem Cells

Volumn 20, Issue 6, 2002, Pages 573-582

  Kadereit, Suzanne ^a   Deeds, Linda S ^a   Haynesworth, Stephen E ^b   Koc, Omer N ^a,c   Kozik, Margaret M ^a   Szekely, Emese ^c   Daum Woods, Kathleen ^c   Goetchius, Glenn W ^a   Fu, Pingfu ^b   Welniak, Lisbeth A ^d   Murphy, William J ^d   Laughlin, Mary J ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

Expansion; Hematopoietic progenitors; Mesenchymal stem cells; UCB

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; PROTEIN BCL 2; PROTEIN P21; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD38 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; APOPTOSIS; ARTICLE; BONE MARROW; CELL FUNCTION; COLONY FORMING UNIT; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MESENCHYME CELL; MICROENVIRONMENT; MIXED LYMPHOCYTE CULTURE; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD BLOOD; ADULT; BIOSYNTHESIS; CELL COMMUNICATION; CELL DIVISION; CHEMISTRY; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PHYSIOLOGY;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL DIVISION; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS); STEM CELLS;

EID: 0036458679     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.20-6-573     Document Type: Article

References (37)

1. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822.
2. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
3. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
4. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-381.
5. Paulin T. Importance of bone marrow cell dose in bone marrow transplantation. Clin Transplant 1992;6:48-54.
6. Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-1854.
7. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25:797-799.
8. Kogler G, Nurnberger W, Fischer J et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999;24:397-403.
9. Koller MR, Manchel I, Maher RJ et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998;21:653-663.
10. Gupta P, Oegema Jr TR, Brazil JJ et al. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: Requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 2000;95:147-155.
11. Kiger AA, White-Cooper H, Fuller MT. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature 2000;407:750-754.
12. Tran J, Brenner TJ, DiNardo S. Somatic control over the germline stem cell lineage during Drosophila spermatogenesis. Nature 2000;407:754-757.
13. Xie T, Spradling AC. A niche maintaining germ line stem cells in the Drosophila ovary. Science 2000;290:328-330.
14. Kiger AA, Jones DL, Schulz C et al. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 2001;294:2524-2545.
15. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
16. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66.
17. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
18. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996;166:585-592.
19. Majumdar MK, Thiede MA, Haynesworth SE et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000;9:841-848.
20. Gough NM, Williams RL, Hilton DJ et al. LIF: A molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells. Reprod Fertil Dev 1989;1:281-288.
21. Murray P, Edgar D. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). Differentiation 2001;86:227-234.
22. Kadereit S, Mohammad SF, Miller RE et al. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 1999;94:3101-3107.
23. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997;94:9836-9841.
24. Davis BM, Reese JS, Koc ON et al. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1997;57:5093-5099.
25. Sutherland HJ, Lansdorp PM, Henkelman DH et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 1990;87:3584-3588.
26. cip1/waf1. Science 2000;287:1804-1808.
27. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med 2000;191:253-264.
28. Gerson SL. Mesenchymal stem cells: No longer second class marrow citizens. Nat Med 1999;5:262-264.
29. Verfaillie CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993;82:2045-2053.
30. + cord blood and bone marrow cells. Ann Hematol 2000;79:59-65.
31. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 1992;79:2821-2826.
32. Shimakura Y, Kawada H, Ando K et al. Murine stromal cell line HESS-5 maintains reconstituting ability of ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood. STEM CELLS 2000;18:183-189.
33. Kusadasi N, Koevoet JL, van Soest PL et al. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells. Leukemia 2001;15:1347-1358.
34. Marone M, Bonanno G, Rutella S et al. Survival and cell cycle control in early hematopoiesis: Role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21. Leuk Lymphoma 2002;43:51-57.
35. 1 checkpoint control. Cell 1995;82:675-684.
36. Mantel C, Luo Z, Canfield J et al. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 1996;88:3710-3719.
37. cip1/wafcip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer. Blood Cells Mol Dis 1998;24:138-148.